TH17 is a lymphocyte subset, which is characterized by its polarization to secrete interleukin (IL)-17. IL-23 is the pivotal mediator responsible for TH17 differentiation and the IL-23/IL-17 axis has been strongly implicated in the pathogenesis of several immune mediated diseases, in particular chronic arthritis and skin psoriasis. This review will summarize the basic immunology and the new monoclonal antibodies, which antagonize this pathway allowing a new therapeutic approach.
CITATION STYLE
Cauli, A., Piga, M., Floris, A., & Mathieu, A. (2015). Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis). ImmunoTargets and Therapy, 185. https://doi.org/10.2147/itt.s62870
Mendeley helps you to discover research relevant for your work.